Journal News

New tool matches microbial and metabolic metaproteomic data

Ecem Arpaci
By Ecem Arpaci
April 30, 2025

Metaproteomics is the study of all proteins expressed in entire communities, such as soil and gut microbiomes, and often requires bioinformatics approaches to analyze large quantities of data. However, until recently, none of these tools mapped protein or peptide data onto information about their biological functions.

To address this gap, in a recent study in Molecular & Cellular Proteomics, Tibo Vande Moortele of Ghent University and an international team of researchers created PathwayPilot. This bioinformatics resource combines proteomic data, including protein identification and abundances, with metabolic pathway data. Users can upload peptide or protein data, choose their desired pathways for analysis and export the results in various formats for further analysis. This makes it easier for researchers to identify the biochemical functions of proteins between organisms in a microbial community or between communities. The team tested PathwayPilot’s accuracy by analyzing data from a study on lipid metabolism and found that nearly all results matched to a known pathway.

Researchers can use this tool to compare the metaproteomic effects of environmental factors such as temperature or determine the role of a microorganism in its community, with promising applications in medical microbiology and ecology. PathwayPilot currently can only be used to compare two groups, so the team plans to continue updating the resource.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Ecem Arpaci
Ecem Arpaci

Ecem Arpaci is a biochemistry student at Imperial College London and a research intern at Radboud University Medical Center. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.